A New Dimension in Precision Oncology with the SPOT-LX DNA Repair Testing Platform

Time: 11:50 am
day: Day One


• LXRepair develops funtional repair assays for a comprehensive characterization of major repair pathways in parallel
• Inhibitors specificity and efficacy can be rapidly investigated
• Assays can be used to stratify patients and monitor patients response to various DNA damaging drugs and DDR inhibitors